Critical Appraisal Of The Financial Impact Of Implementing The Rules Of Resolution Of Brazilian Chamber Of Economic Regulation Of Pharmaceuticals (CMED) N° 2/2004 On The Prices Of New Medicines In Brazil
Abstract
Authors
M.D.O. Fernandes M.V.R. Wehner G.C. Garcia T.R. Caldeira M.A.K. Ronchini G.C.B.C.E.C. Troncoso